US5047533A
(en)
*
|
1983-05-24 |
1991-09-10 |
Sri International |
Acyclic purine phosphonate nucleotide analogs
|
US4845084A
(en)
*
|
1984-01-26 |
1989-07-04 |
Merck & Co., Inc. |
Phosphate derivatives of substituted butyl guanines, antiviral compositions containing them, and methods of treating viral infections with them
|
CS264222B1
(en)
*
|
1986-07-18 |
1989-06-13 |
Holy Antonin |
N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
|
US5650510A
(en)
*
|
1986-11-18 |
1997-07-22 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
|
IL84477A
(en)
*
|
1986-11-18 |
1995-12-08 |
Bristol Myers Squibb Co |
History of Phosphonomethoxyalkylene Purinopyrimidine and Pharmaceutical Preparations Containing Them
|
EP0319228B1
(en)
*
|
1987-11-30 |
1994-11-02 |
Beecham Group Plc |
Novel compounds
|
US5247085A
(en)
*
|
1987-11-30 |
1993-09-21 |
Beecham Group P.L.C. |
Antiviral purine compounds
|
EP0335770B1
(en)
*
|
1988-04-01 |
1997-01-15 |
Merrell Pharmaceuticals Inc. |
Novel fluorophosphonate nucleotide derivatives
|
EP0339161A1
(en)
*
|
1988-04-01 |
1989-11-02 |
Merrell Dow Pharmaceuticals Inc. |
Novel fluorophosphonate nucleotide derivatives
|
US5284837A
(en)
*
|
1988-05-06 |
1994-02-08 |
Medivir Ab |
Derivatives of purine, process for their preparation and a pharmaceutical preparation
|
EP0353955A3
(en)
*
|
1988-08-02 |
1991-08-14 |
Beecham Group Plc |
Novel compounds
|
US5744600A
(en)
*
|
1988-11-14 |
1998-04-28 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Phosphonomethoxy carbocyclic nucleosides and nucleotides
|
US4966895A
(en)
*
|
1989-02-02 |
1990-10-30 |
Merck & Co. Inc. |
Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
|
US5688778A
(en)
*
|
1989-05-15 |
1997-11-18 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Nucleoside analogs
|
GB8912043D0
(en)
*
|
1989-05-25 |
1989-07-12 |
Beecham Group Plc |
Novel compounds
|
US5302585A
(en)
*
|
1990-04-20 |
1994-04-12 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
|
CS387190A3
(en)
*
|
1990-08-06 |
1992-03-18 |
Ustav Organicke Chemie A Bioch |
(2r)-2-/di(2-propyl)phosphonylmethoxy/-3-p-toluenesulfonyloxy -1- trimethylacetoxypropane and process for preparing thereof
|
JP3116079B2
(ja)
*
|
1990-08-10 |
2000-12-11 |
インスティチュート オブ オーガニック ケミストリ アンド バイオケミストリ アカデミー オブ サイエンス オブ ザ チェコ リパブリック |
ヌクレオチドの新規な製法
|
ES2118069T3
(es)
*
|
1990-09-14 |
1998-09-16 |
Acad Of Science Czech Republic |
Profarmacos de fosfonatos.
|
US5208221A
(en)
*
|
1990-11-29 |
1993-05-04 |
Bristol-Myers Squibb Company |
Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
|
US6057305A
(en)
*
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
US5514798A
(en)
*
|
1993-06-02 |
1996-05-07 |
Gilead Sciences, Inc. |
Method and cyclic carbonates for nucleotide analogues
|
US5656745A
(en)
*
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
KR100386685B1
(ko)
*
|
1993-09-17 |
2003-12-31 |
길리애드 사이언시즈, 인코포레이티드 |
뉴클레오타이드동족체류
|
US5798340A
(en)
*
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
DE4408534A1
(de)
*
|
1994-03-14 |
1995-09-28 |
Hoechst Ag |
Substituierte N-Ethyl-Glycinderivate zur Herstellung von PNA und PNA-/DNA-Hybriden
|
US6465650B1
(en)
|
1995-03-13 |
2002-10-15 |
Aventis Pharma Deutschland Gmbh |
Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
|
US5977061A
(en)
*
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5877166A
(en)
*
|
1996-04-29 |
1999-03-02 |
Sri International |
Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
|
US5733788A
(en)
*
|
1996-07-26 |
1998-03-31 |
Gilead Sciences, Inc. |
PMPA preparation
|
DE122005000041I2
(de)
*
|
1996-07-26 |
2012-05-24 |
Gilead Sciences Inc |
Nukleotidanaloga.
|
US5935946A
(en)
*
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
PT1243590E
(pt)
*
|
1997-07-25 |
2005-05-31 |
Gilead Sciences Inc |
Composicao de analogos nuclotidicos e metodo de sintese
|
AU2645199A
(en)
*
|
1998-11-18 |
2000-06-05 |
Viktor Veniaminovich Tets |
Dialkyl-1-aryl-1-(2,4-dioxo-5-amino-1,3-pyrimidin-5-yl)methy lphosphonates
|
US7205404B1
(en)
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
NZ535408A
(en)
|
2000-07-21 |
2006-09-29 |
Gilead Sciences Inc |
Method for selecting prodrugs of phosphonate nucleotide analogues
|
KR100891366B1
(ko)
|
2001-06-29 |
2009-04-02 |
인스티튜트 오브 오르가닉 케미스트리 앤드 바이오케미스트리, 어케더미 오브 사이언시스 오브 더 체크 리퍼블릭 |
항 바이러스 활성을 갖는 6-'2-(포스포노메톡시)알콕시 피리미딘 유도체
|
IL161901A0
(en)
*
|
2001-11-14 |
2005-11-20 |
Biocryst Pharmaceuticals Inc A |
Nucleosides, preparation thereof and use as inhibiDevice for the reading and the signalling of environmental parameters tors of rna viral polymerases
|
US7388002B2
(en)
|
2001-11-14 |
2008-06-17 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
CA2485597C
(en)
|
2002-05-13 |
2013-07-02 |
Metabasis Therapeutics, Inc. |
Process for preparation of cyclic prodrugs of pmea and pmpa
|
WO2004037161A2
(en)
|
2002-05-13 |
2004-05-06 |
Metabasis Therapeutics, Inc. |
Cyclic prodrugs of pmea one of its analogues
|
KR20050086519A
(ko)
*
|
2002-11-12 |
2005-08-30 |
티안진 킨슬리 파마슈티컬 컴퍼니 리미티드 |
새로운 결정 형태를 가진 아데포비어 디피복실 및 그조성물
|
CN105596356A
(zh)
|
2003-01-14 |
2016-05-25 |
吉里德科学公司 |
用于联合抗病毒治疗的组合物和方法
|
DK1644389T3
(da)
*
|
2003-06-16 |
2011-05-09 |
Acad Of Science Czech Republic |
Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
|
US7579332B2
(en)
*
|
2003-07-30 |
2009-08-25 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
EP1753762B1
(en)
*
|
2004-06-08 |
2014-03-19 |
Metabasis Therapeutics, Inc. |
Lewis acid mediated synthesis of cyclic esters
|
CN100338080C
(zh)
*
|
2004-06-16 |
2007-09-19 |
山东中科泰斗化学有限公司 |
9-[2-(膦羧基甲氧基)乙基]腺嘌呤双环醇酯及其制备方法
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
US8101745B2
(en)
*
|
2004-12-16 |
2012-01-24 |
The Regents Of The University Of California |
Lung-targeted drugs
|
WO2006130217A2
(en)
*
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
KR101294467B1
(ko)
|
2005-07-25 |
2013-09-09 |
인터뮨, 인크. |
C형 간염 바이러스 복제의 신규 거대고리형 억제제
|
US7737273B2
(en)
*
|
2005-07-26 |
2010-06-15 |
Hetero Drugs Limited |
Process for acyclic phosphonate nucleotide analogs
|
AU2006301966A1
(en)
*
|
2005-10-11 |
2007-04-19 |
Array Biopharma, Inc. |
Compounds and methods for inhibiting hepatitis C viral replication
|
WO2007068934A2
(en)
*
|
2005-12-14 |
2007-06-21 |
Cipla Limited |
Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit
|
FR2908133B1
(fr)
*
|
2006-11-08 |
2012-12-14 |
Centre Nat Rech Scient |
Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
|
US8236797B2
(en)
|
2007-06-18 |
2012-08-07 |
Sunshine Lake Pharma Co., Ltd. |
Bromo-phenyl substituted thiazolyl dihydropyrimidines
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
WO2009120358A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Nektar Therapeutics |
Oligomer-nitrogenous base conjugates
|
US7935817B2
(en)
*
|
2008-03-31 |
2011-05-03 |
Apotex Pharmachem Inc. |
Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
|
WO2009142842A2
(en)
*
|
2008-04-15 |
2009-11-26 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
TW201010692A
(en)
|
2008-06-19 |
2010-03-16 |
Public Univ Corp Nagoya City Univ |
Pharmaceutical composition for treatment or prevention of hbv infection
|
EP2358736A1
(en)
*
|
2008-10-15 |
2011-08-24 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
PA8855601A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Forformidatos de nucleósidos
|
KR20110104074A
(ko)
|
2008-12-23 |
2011-09-21 |
파마셋 인코포레이티드 |
퓨린 뉴클레오시드의 합성
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
EP2411392B1
(en)
|
2009-03-26 |
2014-02-26 |
Daewoong Pharmaceutical Co., Ltd. |
Novel crystal forms of adefovir dipivoxil and processes for preparing the same
|
CN102741270B
(zh)
*
|
2009-09-28 |
2015-07-22 |
英特穆恩公司 |
C型肝炎病毒复制的环肽抑制剂
|
US20110082182A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
CA2794671C
(en)
|
2010-03-31 |
2018-05-01 |
Gilead Pharmasset Llc |
Stereoselective synthesis of phosphorus containing actives
|
US20130115237A1
(en)
|
2010-06-09 |
2013-05-09 |
Vaccine Technologies, Incorporated |
Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
|
ES2551738T3
(es)
|
2010-06-11 |
2015-11-23 |
Gilead Sciences, Inc. |
Formulaciones tópicas antivirales para la prevención de la transmisión del VHS-2
|
FI2648701T3
(fi)
|
2010-12-10 |
2023-06-12 |
Sigmapharm Laboratories Llc |
Hyvin stabiileja adefovirdipivoksiilin koostumuksia
|
WO2012154698A2
(en)
*
|
2011-05-06 |
2012-11-15 |
Mckenna Charles E |
Method to improve antiviral activity of nucleotide analogue drugs
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
WO2014068265A1
(en)
|
2012-10-29 |
2014-05-08 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
WO2014143643A1
(en)
|
2013-03-15 |
2014-09-18 |
The Regents Of The University Of California, A California Corporation |
Acyclic nucleoside phosphonate diesters
|
AU2015217221A1
(en)
|
2014-02-13 |
2016-08-11 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and their uses
|
US10167302B2
(en)
*
|
2014-05-23 |
2019-01-01 |
University College Cork |
Phosphonate nucleosides useful in the treatment of viral diseases
|
CN106687118A
(zh)
|
2014-07-02 |
2017-05-17 |
配体药物公司 |
前药化合物及其用途
|
EA036391B1
(ru)
|
2014-09-15 |
2020-11-05 |
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния |
Нуклеотидные аналоги
|
WO2017048956A1
(en)
|
2015-09-15 |
2017-03-23 |
The Regents Of The University Of California |
Nucleotide analogs
|
EP3372227A1
(en)
|
2017-03-06 |
2018-09-12 |
MH10 Spolka z ograniczona odpowiedzialnoscia |
Tablet formulation of adefovir dipivoxil
|
EP3737676B1
(en)
|
2018-01-09 |
2024-03-06 |
Ligand Pharmaceuticals, Inc. |
Acetal compounds and therapeutic uses thereof
|